Brian Longo

Advisor | Board Member | x-Veeva | Focused on Improving Patient Health

📍 United States🔄 Updated September 2026💼 3 investments📅 5 years investing🗓 Last invested Aug 2024
VC🌍 United States
3
Total investments
1
Early stage
2
Mid stage
0
Late stage
5y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Aug 2024
Courier Health is on a mission to solve one of the biggest and most meaningful opportunities in healthcare: reinvent how people living with chronic and rare diseases are supported. We are building the future of patient engagement for life sciences companies. Our software is leveraged by biopharma companies to support patients in their complex journey from diagnosis to initiating and remaining on therapy to achieve optimal health outcomes. Please be aware of recruitment scams. All candidate communication will come from an official @courierhealth.com email address.
Board Member
Apr 2022
Mendel AI supercharges clinical data workflows by coupling large language models with a proprietary clinical hypergraph, delivering scalable clinical reasoning without hallucinations and ensuring 100% explainability. Headquartered in San Jose, California, Mendel is backed by blue-chip investors, including Oak HC/FT and DCM.
Advisor and Investor
Oct 2021
We are Stitch. We’re on a mission to make clinical trials better by measuring each patient’s experience. We listen to and amplify each patients voice. Feedback and reviews are key to making informed choices in everyday decision making, and we are bringing this to clinical trials. This is a huge opportunity to have a real impact on peoples lives. By making clinical trials faster and more efficient, we can get groundbreaking interventions to market more quickly, and improve the path to health for everybody.
Experience · 4 entries
All (4)
Investments (3)
Board (2)
2024
Board Member
Aug 2024
Courier Health is on a mission to solve one of the biggest and most meaningful opportunities in healthcare: reinvent how people living with chronic and rare diseases are supported. We are building the future of patient engagement for life sciences companies. Our software is leveraged by biopharma companies to support patients in their complex journey from diagnosis to initiating and remaining on therapy to achieve optimal health outcomes. Please be aware of recruitment scams. All candidate communication will come from an official @courierhealth.com email address.
2022
Board Member
Apr 2022
Mendel AI supercharges clinical data workflows by coupling large language models with a proprietary clinical hypergraph, delivering scalable clinical reasoning without hallucinations and ensuring 100% explainability. Headquartered in San Jose, California, Mendel is backed by blue-chip investors, including Oak HC/FT and DCM.
2021
Advisor and Investor
Oct 2021
We are Stitch. We’re on a mission to make clinical trials better by measuring each patient’s experience. We listen to and amplify each patients voice. Feedback and reviews are key to making informed choices in everyday decision making, and we are bringing this to clinical trials. This is a huge opportunity to have a real impact on peoples lives. By making clinical trials faster and more efficient, we can get groundbreaking interventions to market more quickly, and improve the path to health for everybody.
2001
Consultant
Aug 2001
Accenture helps the world’s leading enterprises reinvent by building their digital core and unleashing the power of AI to create value at speed for organizations across industries. Our strategy is to be the reinvention partner of choice for our clients and lead in the safe, widespread adoption of AI, and to be the most client-focused, AI-enabled, great place to work in the world. We bring together the talent of our approximately 786,000 people with proprietary assets and platforms, deep process and industry expertise, and leading ecosystem relationships to deliver end-to-end solutions and measurable outcomes at scale. Through our Reinvention Services, we offer broad expertise across Cybersecurity, Digital Core, Finance, Industry and Enterprise, Song, Supply Chain and Engineering, and Talent, with advanced capabilities in AI and Data, Industry and Process, and Technology. We serve approximately 9,000 clients and generated approximately $70 billion in FY25 revenue. Visit us at accenture.com. This LinkedIn company page is moderated. When engaging with Accenture, we encourage everyone to: - Use common courtesy and be respectful of others. - Create your own original content and avoid content that you know to be fraudulent. - Never repost someone elses copyrighted work, unless you have permission. - Never post personal, identifying, or confidential information. We reserve the right to delete comments or posts we deem to be: - Profane, obscene, inappropriate, offensive, abusive material. - Spam, repeated comments and commercial messages and personal advertisements. - Discriminatory or that contain hateful speech of any kind regarding age, gender, race, religion, nationality, sexual orientation, gender identity or disability. - Threats; personal attacks; abusive, defamatory, derogatory, or inflammatory language; or stalking or harassment of any individual, entity or organization. - False, inaccurate, libelous, or otherwise misleading in any way.
Investment activity
2021–2024 · 3 investments
202112022120241
Recent (last 2 years)Earlier